Three months’ clinical outcomes from a nationwide non-medical switch from originator to biosimilar infliximab in patients with in flammatory arthritis: Results from the DANBIO registry

B Glintborg, I J Sørensen, D V Jensen, N S Krogh, A G Loft, A Colic, J Espesen, J Olsen, O Hendricks, J Grydehøj, I M J Hansen, M V Sørensen, S Chrysidis, A Linauskas, H M Lindegaard, B L Andersen, N Manilo, M Klarlund, L S Andersen, H NordinS Kristensen, M L Hetland

Original languageEnglish
Article numberOP07
JournalScandinavian Journal of Rheumatology
Volume45
Issue numbersup128
Number of pages2
ISSN0300-9742
DOIs
Publication statusPublished - 2016

Cite this